TrialNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2018

Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial.

Mona Ahmadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.